Interestingly, tumor cells may also produce itaconate intrinsically, which paradoxically enhances tumor immunogenicity by increasing MHC-I expression and type I interferon signalling, resulting in higher CD8+ T cell infiltration [22]. The gene discussed is CD8A; the disease is neoplasm.